EP Patent

EP1187633A4 — Use of anti-vegf antibody to enhance radiation in cancer therapy

Assigned to University of Chicago · Expires 2005-05-11 · 21y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: EP1187633A4
Jurisdiction: EP
Classification: —
Expires: 2005-05-11
Drug substance claim: No
Drug product claim: No
Assignee: University of Chicago
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.